Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Recruiting
Checked: September 19, 2026 at 9:53 PM UTC
| NCT Number | NCT07365241 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 531 participants |
| Active Locations | 32 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | September 15, 2026 (4 days ago) |
As of September 19, 2026: Clinical trial NCT07365241 is currently recruiting participants. This phase3 study for small cell lung cancer is actively seeking new participants at 32 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07365241 is actively recruiting participants as of September 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07365241 was last updated 4 days ago (September 15, 2026). HelloStudys verifies this status automatically.